Next Article in Journal
Nanomaterials Applied to Fuel Cells and Catalysts
Previous Article in Journal
Two-Photon Absorption in Twisted Graphene/Hexagonal Boron Nitride Heterojunction Tuned by Vertical Electric Field
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Enhanced FGF21 Delivery via Neutrophil-Membrane-Coated Nanoparticles Improves Therapeutic Efficacy for Myocardial Ischemia–Reperfusion Injury

1
School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China
2
Oujiang Laboratory, Wenzhou 325000, China
3
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
*
Authors to whom correspondence should be addressed.
Nanomaterials 2025, 15(5), 346; https://doi.org/10.3390/nano15050346
Submission received: 7 January 2025 / Revised: 15 February 2025 / Accepted: 21 February 2025 / Published: 23 February 2025
(This article belongs to the Section Biology and Medicines)

Abstract

Acute myocardial infarction, a leading cause of death globally, is often associated with cardiometabolic disorders such as atherosclerosis and metabolic syndrome. Metabolic treatment of these disorders can improve cardiac outcomes, as exemplified by the GLP-1 agonist semaglutide. Fibroblast growth factor 21 (FGF21), a novel metabolic regulator, plays pivotal roles in lipid mobilization and energy conversion, reducing lipotoxicity, inflammation, mitochondrial health, and subsequent tissue damage in organs such as the liver, pancreas, and heart. Here, we test the therapeutic efficacy of FGF21 in mice with ischemia–reperfusion (I/R) injury, a model of acute myocardial infarction. We employed the strategic method of coating the FGF21-encapsulating liposomal nanoparticles with a neutrophil membrane designed to camouflage FGF21 from macrophage-mediated efferocytotic clearance and promote its targeted accumulation at I/R foci due to the inherent neutrophilic attraction to the inflammatory site. Our findings revealed that the coated FGF21 nanoparticles markedly accumulated within the lesions with a prolonged half-life, in additional to the liver, leading to substantial improvements in cardiac performance by enhancing mitochondrial energetic function and reducing oxidative stress, inflammation, and cell death. Therefore, our research highlights a viable strategy for the enhanced delivery of therapeutical FGF21 analogs to lesions beyond the liver following myocardial infarction.
Keywords: neutrophil-membrane-coated nanoparticle; fibroblast growth factor 21 (FGF21); drug delivery; ischemia and reperfusion injury; myocardial infarction neutrophil-membrane-coated nanoparticle; fibroblast growth factor 21 (FGF21); drug delivery; ischemia and reperfusion injury; myocardial infarction

Share and Cite

MDPI and ACS Style

Rao, Z.; Tang, Y.; Zhu, J.; Lu, Z.; Chen, Z.; Wang, J.; Bao, Y.; Mukondiwa, A.V.; Wang, C.; Wang, X.; et al. Enhanced FGF21 Delivery via Neutrophil-Membrane-Coated Nanoparticles Improves Therapeutic Efficacy for Myocardial Ischemia–Reperfusion Injury. Nanomaterials 2025, 15, 346. https://doi.org/10.3390/nano15050346

AMA Style

Rao Z, Tang Y, Zhu J, Lu Z, Chen Z, Wang J, Bao Y, Mukondiwa AV, Wang C, Wang X, et al. Enhanced FGF21 Delivery via Neutrophil-Membrane-Coated Nanoparticles Improves Therapeutic Efficacy for Myocardial Ischemia–Reperfusion Injury. Nanomaterials. 2025; 15(5):346. https://doi.org/10.3390/nano15050346

Chicago/Turabian Style

Rao, Zhiheng, Yuli Tang, Jiamei Zhu, Zhenzhen Lu, Zhichao Chen, Jiaojiao Wang, Yuxuan Bao, Alan Vengai Mukondiwa, Cong Wang, Xiaojie Wang, and et al. 2025. "Enhanced FGF21 Delivery via Neutrophil-Membrane-Coated Nanoparticles Improves Therapeutic Efficacy for Myocardial Ischemia–Reperfusion Injury" Nanomaterials 15, no. 5: 346. https://doi.org/10.3390/nano15050346

APA Style

Rao, Z., Tang, Y., Zhu, J., Lu, Z., Chen, Z., Wang, J., Bao, Y., Mukondiwa, A. V., Wang, C., Wang, X., Luo, Y., & Li, X. (2025). Enhanced FGF21 Delivery via Neutrophil-Membrane-Coated Nanoparticles Improves Therapeutic Efficacy for Myocardial Ischemia–Reperfusion Injury. Nanomaterials, 15(5), 346. https://doi.org/10.3390/nano15050346

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop